Document Detail


The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
MedLine Citation:
PMID:  3011235     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A program to reduce the incidence of erythroblastosis fetalis was started in Nova Scotia in 1964. Up to the end of 1984, 120 fetuses received 247 intrauterine transfusions. The survival rate was 45.6% in the first 10 years of the program and 66.7% in the next 11 years. For fetuses at or over 26 weeks' gestation the figures were 51.5% and 73.7% respectively. Postpartum prevention was started in 1968, with administration of Rh immune globulin (RhIG) to Rh-negative unimmunized women within 72 hours after the birth of an Rh-positive infant. Antepartum prevention, started in 1979, consisted of administration of RhIG at 28 weeks' gestation to Rh-negative unimmunized women. The effectiveness of the prevention program was evaluated by enumerating the known cases of Rh(D) alloimmunization in the province from 1982 to 1984: 55 cases were identified, a rate of 1.5 per 1000 births instead of the expected rate of about 10 per 1000.
Authors:
T F Baskett; M L Parsons; L J Peddle
Related Documents :
21098155 - Febrile infants with urinary tract infections at very low risk for adverse events and b...
15868595 - Failure of cholecystokinin-octapeptide to prevent tpn-associated gallstone disease.
21564235 - Bootstrapping the mind: analogical processes and symbol systems.
1649005 - Evaluation of the effects of a pyrophosphate-fluoride anticalculus dentifrice on remine...
17474975 - Malaria vector control by indoor residual insecticide spraying on the tropical island o...
6405725 - Hypoxic-ischemic encephalopathy in the newborn.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne     Volume:  134     ISSN:  0820-3946     ISO Abbreviation:  CMAJ     Publication Date:  1986 Jun 
Date Detail:
Created Date:  1986-06-30     Completed Date:  1986-06-30     Revised Date:  2010-09-09    
Medline Journal Info:
Nlm Unique ID:  9711805     Medline TA:  CMAJ     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1259-61     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Transfusion, Intrauterine
Erythroblastosis, Fetal / mortality,  prevention & control,  therapy*
Female
Humans
Immunization, Passive
Immunoglobulins / administration & dosage
Infant, Newborn
Nova Scotia
Pregnancy
Rh Isoimmunization / prevention & control
Rh-Hr Blood-Group System
Rho(D) Immune Globulin
Chemical
Reg. No./Substance:
0/Immunoglobulins; 0/Rh-Hr Blood-Group System; 0/Rho(D) Immune Globulin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surgical treatment of lung cancer: promise and problems of early diagnosis.
Next Document:  Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prog...